Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.
about
Endocannabinoids in the retina: from marijuana to neuroprotectionCannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling.Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts.A firmer understanding of the effect of hypergravity on thyroid tissue: cholesterol and thyrotropin receptorDiverse roles of G-protein coupled receptors in the regulation of neurohypophyseal hormone secretion.CB2 receptors in reproduction.Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.Gangliosides as components of lipid membrane domains.Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levelsThe interaction of cannabinoid receptor agonists, CP55940 and WIN55212-2 with membranes using solid state 2H NMR.Target flexibility: an emerging consideration in drug discovery and design.Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.Endocannabinoid-mediated control of synaptic transmission.Real time monitoring of membrane GPCR reconstitution by plasmon waveguide resonance: on the role of lipids.GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raftPentabromophenol suppresses TGF-β signaling by accelerating degradation of type II TGF-β receptors via caveolae-mediated endocytosis.CD36- and GPR120-mediated Ca²⁺ signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice.Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells.Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?Impact of embedded endocannabinoids and their oxygenation by lipoxygenase on membrane properties.LAT--an important raft-associated transmembrane adaptor protein. Delivered on 6 July 2009 at the 34th FEBS Congress in Prague, Czech Republic.Good news for CB1 receptors: endogenous agonists are in the right place.The potent effect of mycolactone on lipid membranes.Diverse arrestin-recruiting and endocytic profiles of tricyclic antipsychotics acting as direct α2A adrenergic receptor ligands.Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerolExosome-mediated regulation of tumor immunology
P2860
Q24656049-1B6F4CA8-5945-4259-ADE8-BCB2D78EFFB0Q34098179-5E35E7AE-87F2-4EA3-B447-142C46066BBAQ34201750-0D8BE6D2-C08E-4E93-BE25-260CADF46C1CQ34317331-887B1D8F-6DC9-4F4D-BE56-A5509A44F21EQ34317508-29ED8AF4-6B5E-4BE5-B5A5-6B15DC537E24Q35080516-4A588B56-BD15-4513-8AFF-C9FFE9134108Q35174947-099DF3E3-A27D-4AEB-923C-0C5FE717DA00Q35856948-9ED12F21-3762-4531-8777-C2A9C724E5D9Q36416353-27DFF520-2277-4B4C-A244-8F7A910628A5Q36416357-0E4EB8EF-D65C-40AC-BF15-FA96B2485F6FQ36597110-FDDF5C26-5E61-4682-9094-8F39635DDA0EQ36662387-36B294EB-F834-48A0-B121-D822852046B2Q36971357-043D8AF9-EFFF-47BC-845C-4226FF337A30Q37240137-1C38E1D5-A911-4215-B3F1-E30A2F024E76Q37320385-53C4FE20-61A8-418C-8845-2787638B4651Q37363621-69B21A7F-5CE3-48B1-AA76-3B734F32FDDDQ37400201-D1416099-2624-4636-B80B-E818CD55753CQ37479415-C5A85BAF-12C0-43F2-9E2D-B0B5BA7DACC8Q37660994-06D98B7D-E2E0-4DFE-B8FE-A0FFDD4129DAQ37691783-86F639FE-AF1B-4F76-94BC-7D1654EA6FBDQ37842745-46B5C69B-C864-4A7A-8F97-E0B4CF29BE08Q38115668-B365AB5D-6C68-478A-8897-D1CFD66D514AQ39568285-2E3DD9AB-8F44-4312-A420-D8529432CA02Q40090497-20490EE0-522B-40D4-A8B6-2040F9266A6BQ42054026-DE8E6691-1388-4FC5-8F2A-DB2B7815BC60Q42220568-6887CF7D-6A1D-4748-86E0-775F2D3036C4Q42875306-ACF1BDBF-7348-4B6B-BB66-0FDD84112ECCQ42986826-08090373-CDE1-495F-A21D-22FF33780FF7Q48269589-ADAC5A0D-71E5-430B-8E61-AD94937CBD6DQ50470243-3D7D90D2-1321-445C-A05E-BB46766184BCQ57364805-3840D538-E9D1-401E-9ED3-19ABDD49E797Q58804155-D905B6C9-4ED5-4244-90B8-8699D0161206
P2860
Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@ast
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@en
type
label
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@ast
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@en
prefLabel
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@ast
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@en
P2093
P921
P1433
P1476
Lipids, lipid rafts and caveol ...... to the endocannabinoid system.
@en
P2093
Diane Lynch
Judy Barnett-Norris
Patricia H Reggio
P304
P356
10.1016/J.LFS.2005.05.040
P407
P577
2005-08-01T00:00:00Z